Literature DB >> 29862879

Mediating Effects of Frailty Indicators on the Risk of Sepsis After Cancer.

Justin Xavier Moore1,2,3, Tomi Akinyemiju1,2,4, Alfred Bartolucci5, Henry E Wang6, John Waterbor1, Russell Griffin1.   

Abstract

BACKGROUND: Cancer survivors are at increased risk of sepsis, possibly attributed to weakened physiologic conditions. The aims of this study were to examine the mediation effect of indicators of frailty on the association between cancer survivorship and sepsis incidence and whether these differences varied by race.
METHODS: We performed a prospective analysis using data from the REasons for Geographic and Racial Differences in Stroke cohort from years 2003 to 2012. We categorized frailty as the presence of ≥2 frailty components (weakness, exhaustion, and low physical activity). We categorized participants as "cancer survivors" or "no cancer history" derived from self-reported responses of being diagnosed with any cancer. We examined the mediation effect of frailty on the association between cancer survivorship and sepsis incidence using Cox regression. We repeated analysis stratified by race.
RESULTS: Among 28 062 eligible participants, 2773 (9.88%) were cancer survivors and 25 289 (90.03%) were no cancer history participants. Among a total 1315 sepsis cases, cancer survivors were more likely to develop sepsis (12.66% vs 3.81%, P < .01) when compared to participants with no cancer history (hazard ratios: 2.62, 95% confidence interval: 2.31-2.98, P < .01). The mediation effects of frailty on the log-hazard scale were very small: weakness (0.57%), exhaustion (0.31%), low physical activity (0.20%), frailty (0.75%), and total number of frailty indicators (0.69%). Similar results were observed when stratified by race.
CONCLUSION: Cancer survivors had more than a 2-fold increased risk of sepsis, and indicators of frailty contributed to less than 1% of this disparity.

Entities:  

Keywords:  Cancer; Frailty; Mediation; Sepsis; and Racial Disparities

Mesh:

Year:  2018        PMID: 29862879      PMCID: PMC6026551          DOI: 10.1177/0885066618779941

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  58 in total

1.  Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.

Authors:  Ayal A Aizer; Tyler J Wilhite; Ming-Hui Chen; Powell L Graham; Toni K Choueiri; Karen E Hoffman; Neil E Martin; Quoc-Dien Trinh; Jim C Hu; Paul L Nguyen
Journal:  Cancer       Date:  2014-02-22       Impact factor: 6.860

2.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

3.  Disparities in breast cancer surgery delay: the lingering effect of race.

Authors:  Vanessa B Sheppard; Bridget A Oppong; Regina Hampton; Felicia Snead; Sara Horton; Fikru Hirpa; Echo J Brathwaite; Kepher Makambi; S Onyewu; Marc Boisvert; Shawna Willey
Journal:  Ann Surg Oncol       Date:  2015-02-05       Impact factor: 5.344

4.  Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma.

Authors:  Karin Gwyn; Melissa L Bondy; Deborah S Cohen; Mary Jo Lund; Jonathan M Liff; Elaine W Flagg; Louise A Brinton; J William Eley; Ralph J Coates
Journal:  Cancer       Date:  2004-04-15       Impact factor: 6.860

Review 5.  Pathophysiology of sepsis.

Authors:  Daniel G Remick
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

6.  Sepsis after major cancer surgery.

Authors:  Jesse D Sammon; Dane E Klett; Akshay Sood; Kola Olugbade; Marianne Schmid; Simon P Kim; Mani Menon; Quoc-Dien Trinh
Journal:  J Surg Res       Date:  2014-07-24       Impact factor: 2.192

7.  Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study.

Authors:  Thomas Clark Powell; John P Donnelly; Orlando M Gutiérrez; Russell L Griffin; Monika M Safford; Henry E Wang
Journal:  BMC Nephrol       Date:  2015-04-23       Impact factor: 2.388

8.  Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities.

Authors:  Tomi F Akinyemiju; Amr S Soliman; Norman J Johnson; Sean F Altekruse; Kathy Welch; Mousumi Banerjee; Kendra Schwartz; Sofia Merajver
Journal:  J Cancer Epidemiol       Date:  2013-02-20

9.  Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment.

Authors:  Steve H Kim; Jeanne Ferrante; Bok Ran Won; Meera Hameed
Journal:  World J Surg Oncol       Date:  2008-02-25       Impact factor: 2.754

10.  Mammographic density and breast cancer risk: a mediation analysis.

Authors:  Megan S Rice; Kimberly A Bertrand; Tyler J VanderWeele; Bernard A Rosner; Xiaomei Liao; Hans-Olov Adami; Rulla M Tamimi
Journal:  Breast Cancer Res       Date:  2016-09-21       Impact factor: 6.466

View more
  2 in total

Review 1.  Frailty and aging in cancer survivors.

Authors:  Kirsten K Ness; Matthew D Wogksch
Journal:  Transl Res       Date:  2020-05-01       Impact factor: 7.012

2.  When Eating Becomes Torturous: Understanding Nutrition-Related Cancer Treatment Side Effects among Individuals with Cancer and Their Caregivers.

Authors:  Brandy-Joe Milliron; Lora Packel; Dan Dychtwald; Cynthia Klobodu; Laura Pontiggia; Ochi Ogbogu; Byron Barksdale; Jonathan Deutsch
Journal:  Nutrients       Date:  2022-01-14       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.